拉丁美洲大妈市场前景及投资研究报告-外文版培训课件

POLITICS

&

SOCIETYCannabisinLatinAmericaCHAPTER

01GlobaloverviewEstimatednumberofcannabisusersworldwidefrom2011to2021,byregion*(inmillions)Numberofcannabisusersworldwidebyregion2011-2021Numberofusersinmillions2021

2017

2015

20131002011150050200250219219.02WorldwideAsia237.67232.07230.3261.9964.8488.7889.3887.1153.662.6964.3859.1257.35Africa70.4658.3351.3255.6250.64AmericasEuropeOceania29.4730.2129.4524.3831.713.452.953.733.573.53Description:Therearecurrentlyaround219millioncannabisusersworldwide.ThehighestnumberofcannabisuserscanbefoundintheAmericas,followedbyAsiaandthenAfrica.Theuseofcannabisvariesdependingonthecountryandregionaslawssurroundingthesaleanduseofthedrugdiffergreatly.Somecountriesandregionsmaintainharshpenaltiesforthesaleanduseofcannabiswhileothershavedecriminalizeditandmorerecentlyevencompletelylegalizeditforrecreationalsale[...]

ReadmoreNote(s):Worldwide;15-64years;*Thisstatisticincludesallpersonswhoconsumedcannabisatleastonceintheparticularyear.Allnumbersaremaximumestimates.Datapriorto2021havebeentakenfrompreviouseditionsofthesamesource.

ReadmoreSource(s):UNODCDistributionofcannabisusersworldwideasof2021,bygenderandregionDistributionofcannabisusersworldwideasof2021,bygenderandregionMenWomen20%120%100%80%60%40%20%0%9%12%88%20%20%80%29%71%34%66%37%63%42%58%91%80%80%AfricaAsiaAustraliaandNewZealandCarribeanCentralAmerica

SouthAmericaSouth-EastEuropeNorthAmerica

WestandCentralEurope4/statistics/1332164/cannabis-users-by-gender-and-region-worldwideAsof2021,womenrepresentedaround42percentofcannabisusersinNorthAmerica,whileinAsiaonlyninepercentofcannabisuserswerewomen.Thisstatisticillustratesthedistributionofcannabisusersworldwideasof2021,bygenderandregion.ReadmoreNote(s):Worldwide;2021Source(s):UNODCSalesforecastofmajorpharmaceuticalcannabisproductsworldwidefrom2023to2027(inmillionU.S.dollars)Salesforecastofmajorcannabispharmaceuticalproductsworldwide2023-20271,6001,3731,4001,319.41,259.61,191.91,2001,00080060040020001,113.8202320242025202620275Description:AsofJune2023,itwasforecastedthatin2027globalsalesfortheleadingthreepharmaceuticalcannabisproductswillstandatnearly1.4billionU.S.dollars.ThethreemajorproductsareEpidiolex,Dronabinol,andSativex.Thisstatisticillustratestheestimatedsalesforecastofmajorcannabispharmaceuticalproductsworldwidefrom2023to2027.ReadmoreNote(s):Worldwide;asofJune2023Source(s):ProhibitionPartnersPercentageofclinicaltrialsinvolvingcannabisworldwidebetween2010and2023,bymedicalconditionShareofcannabisclinicaltrialsworldwidebymedicalcondition2010-2023Percentageoftrials20%0%5%10%15%25%30%35%40%45%50%PainEpilepsy46%11.6%Cancer6.8%6.4%5.2%AnxietyMultipleSclerosisPTSD3.6%3.4%HIVOpioiduse2.5%Alzheimer’s2.3%2.3%InflammatoryboweldiseaseInsomnia1.8%Diabetes1.6%1.6%Tourette'ssyndromeParkinson’s1.1%6Description:Between2010and2023,46percentof440clinicaltrialsinvolvingcannabistargetedsomekindofpain.Epilepsywasrankedsecondwitharound12percentoftrials,followedbycancerwithsevenpercentoftrials.Thisstatisticshowsthepercentageofclinicaltrialsinvolvingcannabisworldwidebetween2010and2023,bymedicalcondition.ReadmoreNote(s):Worldwide;January1,2010toMay1,2023;440trialsSource(s):ClinicalT;ProhibitionPartnersMarketvalueofcannabisinLatinAmericafrom2020to2025(inbillionU.S.dollars)LatinAmerica:cannabismarketvalue2020-2025MedicaluseAdultuse454035302538.934.128.923.62014.2151055.95.454.54.23.83.502020202120222023202420257Description:LatinAmerica'slegalcannabismarketisexpectedtogrowsubstantiallyinthecomingyears.Fromavalueof7.3billionU.S.dollarsin2020,themarketisprojectedtoreach44.8billiondollarsby2025.

ReadmoreNote(s):LAC;2021;*Figuresfor2021to2025areestimates.ReadmoreSource(s):NewFrontierDataCHAPTER

02SegmentsRevenueofthecannabismarketinLatinAmericafrom2016to2028(inmillionU.S.dollars)CannabismarketrevenueinLatinAmerica2016-20283,0002,5002,0001,5001,0002,650.312,356.852,062.391,781.421,513.161,256.411,006.22750.52021530.6920205000387.73275.072018198.642017123.122016201920222023202420252026202720289Description:TherevenueofthecannabismarketinLatinAmericawasforecasttocontinuouslyincreasebetween2024and2028byintotal1.1billionU.S.dollars(+75.17percent).Afterthetwelfthconsecutiveincreasingyear,theindicatorisestimatedtoreach2.7billionU.S.dollarsandthereforeanewpeakin2028.Notably,therevenueofthecannabismarketwascontinuouslyincreasingoverthepastyears.ReadmoreNote(s):CentralandSouthAmericaSource(s):AveragerevenueperuserofthelegalcannabismarketinLatinAmericafrom2016to2028CannabisaveragerevenueperuserinLatinAmerica2016-20286.05.04.03.02.04.844.333.813.312.832.361.911.431.021.00.00.750.560.440.41201620172018201920202021202220232024202520262027202810Description:Duringtheperiodanalyzed,theaveragerevenueperuserofthelegalcannabismarketinLatinAmericaisforecasttoincreasefrom0.44U.S.dollarsin2016to4.84U.S.dollarsin2028.Fromthethreesegmentsconsidered(medical,recreation,andtherapeuticcannabis),therapeuticcannabisistheonewiththehighestaveragerevenueperuser.ReadmoreNote(s):CentralandSouthAmericaSource(s):RevenueofthemedicalcannabismarketinLatinAmericafrom2016to2028(inmillionU.S.dollars)MedicalcannabismarketrevenueinLatinAmerica2016-202880706050403076.0168.6561.2953.9246.6639.4132.1224.18202117.252010012.5120198.736.244.172016201720182020202220232024202520262027202811Description:TherevenueofthemedicalcannabissegmentofthecannabismarketinLatinAmericawasforecasttocontinuouslyincreasebetween2024and2028byintotal29.4millionU.S.dollars(+63.01percent).Afterthetwelfthconsecutiveincreasingyear,theindicatorisestimatedtoreach76.01millionU.S.dollarsandthereforeanewpeakin2028.Notably,therevenueofthemedicalcannabismarketwascontinuouslyincreasingoverthepastyears.

ReadmoreNote(s):CentralandSouthAmericaSource(s):RevenueofthetherapeuticcannabismarketinLatinAmericafrom2016to2028(inmillionU.S.dollars)TherapeuticcannabismarketrevenueinLatinAmerica2016-20282,5002,0001,5001,0002,3102,0521,7931,5471,3121,087867.42022643.92021451.75000325.92019227.822018163.1201796.592016202020232024202520262027202812Description:TherevenueofthetherapeuticcannabissegmentofthecannabismarketinLatinAmericawasforecasttocontinuouslyincreasebetween2024and2028byintotal998.3millionU.S.dollars(+76.1percent).Afterthetwelfthconsecutiveincreasingyear,theindicatorisestimatedtoreach2.3billionU.S.dollarsandthereforeanewpeakin2028.Notably,therevenueofthetherapeuticcannabismarketwascontinuouslyincreasingoverthepastyears.

ReadmoreNote(s):CentralandSouthAmericaSource(s):RevenueoftherecreationalcannabismarketinLatinAmericafrom2016to2028(inmillionU.S.dollars)RecreationalcannabismarketrevenueinLatinAmerica2016-2028300250200150264.3236.2208.1180.5154.5130106.7202210082.42202161.7449.32201950038.54201829.322.3620162017202020232024202520262027202813Description:TherevenueoftherecreationalcannabissegmentofthecannabismarketinLatinAmericawasforecasttocontinuouslyincreasebetween2024and2028byintotal109.8millionU.S.dollars(+71.06percent).Afterthetwelfthconsecutiveincreasingyear,theindicatorisestimatedtoreach264.33millionU.S.dollarsandthereforeanewpeakin2028.Notably,therevenueoftherecreationalcannabismarketwascontinuouslyincreasingoverthepastyears.

ReadmoreNote(s):CentralandSouthAmericaSource(s):CHAPTER

03ConsumptionPrevalenceofcannabisuseinLatinAmericaandtheCaribbeanin2021,bysub-regionCannabisuseprevalenceinLatinAmerica&theCaribbean2021,bysub-region7%6%5%4%3%2%1%0%5.73%3.58%3.12%CaribbeanSouthAmericaCentralAmerica15Description:In2021,theCaribbeanwasthesub-regionwiththehighestprevalenceofcannabisuseinLatinAmerica.Thatyear,approximately5.73percentofthepopulationintheCaribbeanhadconsumedcannabisatleastonceduring2021.SouthAmericafollowed,witharound3.58percentofitspopulationbetween15and64yearsusingcannabisatleastonetimewithinthatyear,while3.12percentoftheanalyzedpopulationinCentralAmericahadusedcannabisinthatperiod.Itwasestimated[...]

ReadmoreNote(s):LAC;2021;15-64years;excludingMexicoSource(s):UNODCTypicalwholesalepriceofcannabisinselectedcountriesinLatinAmericain2021(inU.S.dollarsperkilogram)WholesalecannabispriceinLatinAmerica2021,bycountryPriceinU.S.dollarsperkilogram1,500

2,000

2,50005001,0003,0003,5004,0004,5004,239.55TrinidadandTobagoCostaRicaEcuador648.91638Mexico545.28Uruguay254.52160100ElSalvadorBoliviaGuatemalaColombiaHonduras92.1991.183.716Description:In2021,theestimatedtypicalwholesalepriceofcannabisinTrinidadandTobagoamountedto4,239.55U.S.dollarsperkilogram.CostaRicafollowedamongthecountriesanalyzed,withatypicalpriceof649dollarsperkilogram.Meanwhile,inHonduras,thetypicalpriceperkilogramofcannabisaddeduptoanestimated84U.S.dollars.Inthatyear,themarketvalueofmedicalandadultusecannabisinLatinAmericawasestimatedatover18billionU.S.dollars.

ReadmoreNote(s):LAC;2021Source(s):UNODCNumberofusersofmedicalcannabisinLatinAmericafrom2016to2028(in1,000s)MedicalcannabisusersinLatinAmerica2016-20288,0007,0006,0005,0004,0003,0002,0007,041.636,471.955,902.275,303.314,673.114,009.543,310.312,572.911,771.5720201,208.63833.8620181,0000534.582017338.89201620192021202220232024202520262027202817Description:ThenumberofusersofthemedicalcannabissegmentofthecannabismarketinLatinAmericawasforecasttocontinuouslyincreasebetween2024and2028byintotal2.4millionusers(+50.68percent).Afterthetwelfthconsecutiveincreasingyear,theindicatorisestimatedtoreachsevenmillionusersandthereforeanewpeakin2028.Notably,thenumberofmedicalcannabisusersintheregionwascontinuouslyincreasingoverthepastyears.

ReadmoreNote(s):CentralandSouthAmericaSource(s):NumberofusersoftherapeuticcannabisinLatinAmericafrom2016to2028(inmillionusers)TherapeuticcannabisusersinLatinAmerica2016-202816014012010080139.43127.99116.56104.5191.8278.4364.36049.3820214033.61202022.6515.4120182009.545.57201620172019202220232024202520262027202818Description:ThenumberofusersofthetherapeuticcannabissegmentofthecannabismarketinLatinAmericawasforecasttocontinuouslyincreasebetween2024and2028byintotal47.6millionusers(+51.84percent).Afterthetwelfthconsecutiveincreasingyear,theindicatorisestimatedtoreach139.43millionusersandthereforeanewpeakin2028.Notably,thenumberoftherapeuticcannabisusersintheregionwascontinuouslyincreasingoverthepastyears.

ReadmoreNote(s):CentralandSouthAmericaSource(s):NumberofusersofrecreationalcannabisinLatinAmericafrom2016to2028(in1,000s)RecreationalcannabisusersinLatinAmerica2016-202818,00016,00014,00012,00010,0008,00017,095.5115,907.6114,719.7113,372.1611,843.0210,107.348,136.76,0003,51920214,0002,00052.11201667.31201786.932018112.272019145.0120200202220232024202520262027202819Description:ThenumberofusersoftherecreationalcannabissegmentofthecannabismarketinLatinAmericawasforecasttocontinuouslyincreasebetween2024and2028byintotal5.3millionusers(+44.35percent).Afterthetwelfthconsecutiveincreasingyear,theindicatorisestimatedtoreach17.1millionusersandthereforeanewpeakin2028.Notably,thenumberofrecreationalcannabisusersintheregionwascontinuouslyincreasingoverthepastyears.

ReadmoreNote(s):CentralandSouthAmericaSource(s):CHAPTER

04ResearchanddevelopmentMostinnovativecountriesinLatinAmericaandtheCaribbeanin2023,byglobalinnovationindexscoreGlobalinnovationindexinLatinAmericaandtheCaribbean2023,bycountryOverallGIIscore1505102025303540BrazilChile33.633.3Mexico31Uruguay3029.4ColombiaArgentinaCostaRicaPeru2827.927.7Jamaica27.1Panama25.3DominicanRepublicElSalvadorBolivia22.421.821.421Description:AccordingtotheTheGlobalInnovationIndex(GII),BrazilwasthemostinnovativecountryinLatinAmericaandtheCaribbeanin2023,withanoverallGIIscoreof33.6outof100.Mexicorankedthird,withascoreof31.ReadmoreNote(s):LAC;September2023Source(s):WIPONumberofregisteredclinicalstudiesinLatinAmericaasofApril2024,bycountryLatinAmerica:clinicalstudies2024,bycountryNumberofstudies4,000

5,00001,0002,0003,0006,0007,0008,0009,00010,00011,000BrazilMexico9,8714,949ArgentinaChile3,9532,269ColombiaPeru1,9051,244GuatemalaPanama367352CostaRicaDominicanRepublicEcuador240231188188VenezuelaHonduras9822Description:AsofApril2024,BrazilledtherankingofLatinAmericancountrieswithmostclinicaltrials,withcloseto10,000studies.Mexicorankedsecond,withnearly5,000clinicaltrials.Brazilconcentrated4.3percentoftheclinicaltrialsperformedworldwideregardinginfectiousdiseasesin2021.ReadmoreNote(s):LAC;April17,2024Source(s):ClinicalTNumberofregisteredclinicalstudiesrelatedtocannabisinLatinAmericaandtheCaribbeanasofFebruary2024,bycountryClinicalstudiesrelatedtocannabisinLatinAmerica2024,bycountry3.533.02.52.01.51.00.50.0221MexicoJamaicaBrazilChile23Description:AsofFebruary2024,thenumberofregisteredclinicalstudiesrelatedtocannabisinLatinAmericaamountedtoeighttrials.Bycountry,Mexicotoppedthelist,recordingthreeclinicalstudiesinvolvingcannabis.JamaicaandBrazilrankedsecond,withtwomedicalstudieseach.Chilecompletedthelistofregisteredclinicalstudiesoncannabisintheregionasofthatdate.In2021,theCaribbeanstoodastheꢀsub-regionwiththehighestprevalenceofcannabisuseinLatinAmerica.ReadmoreNote(s):LAC;February13,2024Source(s):ClinicalTNumberofregisteredclinicalstudiesrelatedtocannabisinLatinAmericaandtheCaribbeanasofFebruary2024,byphaseClinicalstudiesrelatedtocannabisinLatinAmerica2024,byphaseNumberofstudies0.000.51.01.52.02.5Earlyphase1Phase122Phase2Phase2-3Phase3112Phase424Description:InLatinAmerica,therewereeightregisteredclinicalstudiesrelatedtocannabisasofFebruary2024,mostofwhichtookplaceinMexico,Jamaica,andBrazil.Fromthetotaloftheclinicalstudiesperformedintheregion,twostudieswereonphaseone,twoonphasetwo,oneinphasetwo-three,twoinphasethree,andoneinphasefour.ReadmoreNote(s):LAC;February13,2024Source(s):ClinicalTFundingofselectedcannabiscompaniesinLatinAmericain2022(inmillionU.S.dollars)FundingofcannabiscompaniesinLatinAmerica2022FundinginmillionU.S.dollars02468101214161820ICCLabs*(Uruguay)18Khiron*(Colombia)12.66YVYLifeSciences(Uruguay)1.5CannabisCompanyBuilder(Uruguay)0.525Description:AsofJanuary2023,ICCLabshadattractedinvestmentsof18millionU.S.dollars.ICCLabsisacompanyheadquarteredinMontevideo,Uruguay,anddedicatedtotheproductionofcannabinoidextracts.Asofthatdate,Khiron,amedicalcannabiscompanybasedinthecityofBogotá,Colombia,hadattractedinvestmentsofcloseto13millionU.S.dollars.Asof2021,themarketvalueofcannabisformedicaluseinLatinAmericawasestimatedat14.2billionU.S.dollars.

ReadmoreNote(s):LAC;AsofFebruary2023;*AconversionofCanadiantoU.S.dollarswasmadebasedonfundingrounddates.Thesourcedoesnotspecifythedateofpublication.Thereleasedategivenisthedateofaccess.Thisstatisticwasassembled[...]

ReadmoreSource(s):CrunchBaseCHAPTER

05LegislationandillicitcultivationNumberofcountrieswithapprovedlegislationforcannabisuseinLatinAmericaandtheCaribbeanasof2021,bytypeLegislationofcannabisuseinLatinAmerica&Caribbean2021,bytype109998765432102RecreationaluseMedicinaluseNolegislation27Description:Asof2021,MexicoandUruguayweretheonlytwocountriesinLatinAmericathathadapprovedlegislationrelatedtotheuseofrecreationalcannabis.AnothernineLatinAmericancountries,includingArgentina,Chile,andColombia,hadapprovedlegislationrelatedtothemedicinaluseofcannabis.Asof2023,anestimatedthreemillionpeoplewereconsideredꢀusersofmedicalcannabisintheregion.ReadmoreNote(s):LACSource(s):CNN;Varioussources(CNNEE)NumberofcannabislicensesissuedinUruguayasofDecember2023,bytypeofusageCannabislicensesinUruguay2023,byusageNumberoflicenses40268101214CultivationofpsychoactivecannabisformedicaluseResearch1311Industrialization10AnalyticalLaboratoriesforcannabinoidquantificationCultivationofpsychoactivecannabisforadultuse5328Description:AsofNovember2023,theUruguayangovernmenthadissuedonly13licensesforcultivationofpsychoactivecannabisformedicaluse.Meanwhile,thenumberoflicensesforpsychoactivecannabisforadultusecultivationintheSouthAmericancountryaddeduptothree.ReadmoreNote(s):Uruguay;asofDecember2023Source(s):InstitutefortheRegulationandControlofCannabis(Uruguay);CannabisherbseizuresinselectedcountriesinLatinAmericaandtheCaribbeanin2021(inkilograms)CannabisherbseizuresinLatinAmerican2021,bycountrySeizuresinkilograms200,000

250,000050,000100,000150,000300,000350,000400,000450,000500,000550,000ColombiaBrazilParaguayArgentinaMexico490,984.2410,223387,328254,205.6191,335.95Chile58,617EcuadorPeru33,007.6329,593PanamaCostaRicaHondurasJamaicaBolivia28,30021,660.1918,314.4915,0009,82229Description:In2021,seizuresofcannabisherbinColombiaamountedtoover49